期刊文献+

用于活体成像的小鼠肺癌移植瘤模型的建立 被引量:6

Establishment of xenograft mouse models to study human lung cancer by using in vivo imaging system
原文传递
导出
摘要 本研究旨在建立可用于活体成像的小鼠肺癌移植瘤模型。利用脂质体将荧光素酶表达载体pGL4.17(luc2/neo)转染至人非小细胞肺癌细胞株A549,经G418筛选获得稳定表达荧光素酶的细胞克隆。根据体外生物发光情况及细胞的生长特性,从中挑选合适克隆,进行裸鼠皮下接种,SCID鼠尾静脉接种,建立肺癌移植瘤模型。利用活体成像系统监测肿瘤的生长转移情况,并用切片HE染色进一步验证小鼠模型移植瘤的原位成瘤和转移能力。实验结果表明:本研究成功地构建了可用于活体成像的小鼠肺癌移植瘤模型,模型稳定可靠、直观、灵敏,为肿瘤生长转移机制的研究及抗肿瘤药物的研发提供了重要工具。 We established xenograft mouse models for studying human lung cancer by using an in vivo imaging system. We first transfected pGL4.17 (luc2/neo) plasmid into human non-small lung cancer A549 cells and screened cell lines stably expressing a luciferase reporter gene with G418. Then we analyzed the correlation of luciferase activity and cells number by in vitro bioluminescence. Furthermore, we compared cell growth characteristics by cell counting. We selected suitable clones and inoculated subcutaneously into nude mice or intravenously into SCID mice to construct lung cancer xenograft models. Using an in vivo imaging system, we monitored the growth and metastasis of the tumors. Finally, we verified the extents of tumorigenesis and metastasis by tissue sections with Hematoxylin and Eosin (HE) staining. In our study, we successfully established the xenograft mouse models for in vivo imaging with luciferase expressed lung cancer cells. These models provided convenient, sensitive, intuitive and stable tools for studying the mechanisms of lung cancer progression and development of anticancer drug.
出处 《生物工程学报》 CAS CSCD 北大核心 2009年第8期1204-1210,共7页 Chinese Journal of Biotechnology
基金 国家高技术研究发展计划(863计划)(No.2006AA02Z191) 广州市科技攻关重大项目(No.2007Z1-E4041) 广州经济开发区科技项目(No.2007G-P029)资助~~
关键词 荧光素酶 A549细胞 动物模型 移植瘤 活体成像 luciferase A549 cell animal model xenograft in vivo imaging system
  • 相关文献

参考文献10

  • 1Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin, 2006, 56(2): 106-130.
  • 2Rembrink K, Romijn JC, vanderKwast TH, et al.Orthotopic implantation of human prostate cancer cell lines: a clinically relevant animal model for metastatic prostate cancer. Prostate, 1997, 31(3): 168-174.
  • 3Licha K, Olbrich C. Optical imaging in drug discovery and diagnostic applications. Adv Drug Del Rev, 2005, 57(8): 1087-1108.
  • 4Ray P, Wu AM, Gambhir SS. Optical bioluminescence and positron emission tomography imaging of a novel fusion reporter gene in tumor xenografts of living mice. Cancer Res, 2003, 63(6): 1160-1165.
  • 5Caceres G, Zankina R, Zhu X, et al. Determination of chemotherapeutic activity in vivo by luminescent imaging of luciferase-transfected human tumors. Anticancer Drugs, 2003, 14(7): 569-574.
  • 6Jenkins DE, Oei Y, Hornig YS, et al. Bioluminescent imaging (BLI) to improve and refine traditional murine models of tumor growth and metastasis. Clin Exp Metastasis, 2003, 20(8): 733-744.
  • 7Zeamari S, Rumping G, Floot B, et al. In vivo bioluminescence imaging of locally disseminated colon carcinoma in rats. BrJ Cancer, 2004, 90(6): 1259-1264.
  • 8Brutkiewicz S, Mendonca M, Stantz K, et al. The expression level of luciferase within tumor cells can alter tumor growth upon in vivo bioluminescence imaging. Luminescence, 2007, 22(3): 221-228.
  • 9Yu YA, Timiryasova T, Zhang Q, et al. Optical imaging: bacteria, viruses, and mammalian cells encoding light-emitting proteins reveal the locations of primary tumors and metastases in animals. Anal Bioanal Chem, 2003, 377(6): 964-972.
  • 10Caceres G, Zhu XY, Jiao JA, et al. Imaging of luciferase and GFP-transfected human tumors in nude mice. Luminescence, 2003, 18(4): 218-223.

同被引文献69

  • 1高进.动物肿瘤模型的建立及其标准研讨[J].中国肿瘤生物治疗杂志,1995,2(1):76-79. 被引量:4
  • 2徐冰,姚明,闫明霞,张杰,刘蕾,顾为望.人肝癌NOD-SCID小鼠原位移植模型的建立及其生物学特性的研究[J].肿瘤,2006,26(11):975-978. 被引量:6
  • 3王梅梅,凌斌,赵卫东,周颖,陈峥峥,姚凤球,石永云,高婷,许恬怡,冯定庆,沈国栋,陈敏,朱园园.人子宫内膜癌SCID鼠皮下移植瘤模型的建立及其生物学特性初探[J].安徽医学,2007,28(1):5-7. 被引量:1
  • 4Perez-Soler R, Kemp B, Wu Q P, et al. Response and determinants of sensitivity to paclitaxel in human non-small cell lung cancer tumors heterotransplanted in nude mice. Clin Cancer Res, 2000, 6(12): 4932-4938.
  • 5Fichtner I, KolffJ, Soong K, et al. Establishment of patient-derived non- small cell lung cancer xenografts as models for the identification of predictive biomarkers. Clin Cancer Res, 2008, 14(20): 64S6-6468.
  • 6Bankert RB, Egilmez NK, Hess SD. Human-SCID mouse chimeric models for the evaluation of anti-cancer therapies. Trends Immunol, 2001, 22(7): 386-393.
  • 7Bankert RB, Hess SD, Egilmez NK. SCID mouse models to study human cancer pathogenesis and approaches to therapy: potential, limitations, and future directions. Front Biosci, 2002, 7: c44-c62.
  • 8Dustin ML, de Fougerolles AR. Reprogramming T cells: the role of extracellular matrix in coordination of T ceU activation and migration. Curr Opin Immunol, 2001, 13(3): 286-290.
  • 9Ibe S, Qin Z, Schuler T, et al. Tumor rejection by disturbing tumor stroma cell interactions.J Exp Med, 2001, 194(11): 1549-1559.
  • 10McCawley LJ, Matrisian LM. Tumor progression: defining the soil round the tumor seed. Curt Biol, 2001, 11(1): R25-R27.

引证文献6

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部